Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis-Reference-Cited by-同舟云学术

Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis

Published:2023-01-06 Issue:5 Volume:30 Page:427-436
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Zhang Wencong¹,Xing Mingyou¹,Sun Wenjin²,Chen Jia¹,Xie Nana¹,Cai Yuan³,Wang Ying³,Li Niuniu³,Jiang Yujin³,Zhang Fan³,Wang Yanfeng³,Zeng Qingjin³,Ji Yanhua³,Xu Cheng³,Jiang Chunmei⁴,Song Jianxin¹,Li Guojun³

Affiliation:

1. Department of Infectious Diseases, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. Department of Infectious Diseases Ezhou Central Hospital Ezhou China

3. Department of Liver Diseases, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital The Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases Shenzhen China

4. Department of Infectious Diseases The People's Hospital of Longhua Shenzhen China

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13792

Reference35 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

2. Natural history of serum HBV-RNA in chronic HBV infection

3. Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

4. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years

5. Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study;Frontiers in Cellular and Infection Microbiology;2024-01-16

2. The efficacy and safety of pegylated interferon α-2b-based immunotherapy for inactive hepatitis B surface antigen carriers;European Journal of Gastroenterology & Hepatology;2023-08-14